175 related articles for article (PubMed ID: 18081089)
1. Transcription-inhibition and antitumor activities of N-alkylated tetraazacyclododecanes.
Xiong XQ; Liang F; Yang L; Wang XL; Zhou X; Zheng CY; Cao XP
Chem Biodivers; 2007 Dec; 4(12):2791-7. PubMed ID: 18081089
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the first cytostatically active 1-aza-9-oxafluorenes as novel selective CDK1 inhibitors with P-glycoprotein modulating properties.
Brachwitz K; Voigt B; Meijer L; Lozach O; Schächtele C; Molnár J; Hilgeroth A
J Med Chem; 2003 Feb; 46(5):876-9. PubMed ID: 12593668
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in-vitro cytotoxicity evaluation of novel naphtindolizinedione derivatives, part II: improved activity for aza-analogues.
Defant A; Guella G; Mancini I
Arch Pharm (Weinheim); 2009 Feb; 342(2):80-6. PubMed ID: 19173337
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological activity, and quantitative structure-activity relationship study of azanaphthalimide and arylnaphthalimide derivatives.
Braña MF; Gradillas A; Gómez A; Acero N; Llinares F; Muñoz-Mingarro D; Abradelo C; Rey-Stolle F; Yuste M; Campos J; Gallo MA; Espinosa A
J Med Chem; 2004 Apr; 47(9):2236-42. PubMed ID: 15084122
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones.
Antonini I; Santoni G; Lucciarini R; Amantini C; Dal Ben D; Volpini R; Cristalli G
J Med Chem; 2008 Feb; 51(4):997-1006. PubMed ID: 18232651
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs.
Antonini I; Volpini R; Dal Ben D; Lambertucci C; Cristalli G
Bioorg Med Chem; 2008 Sep; 16(18):8440-6. PubMed ID: 18774722
[TBL] [Abstract][Full Text] [Related]
7. 2-[(Carboxymethyl)sulfanyl]-4-oxo-4-arylbutanoic acids selectively suppressed proliferation of neoplastic human HeLa cells. A SAR/QSAR study.
Drakulić BJ; Juranić ZD; Stanojković TP; Juranić IO
J Med Chem; 2005 Aug; 48(17):5600-3. PubMed ID: 16107160
[TBL] [Abstract][Full Text] [Related]
8. Regioselective synthesis and in vitro anticancer activity of 4-aza-podophyllotoxin derivatives catalyzed by L-proline.
Shi C; Wang J; Chen H; Shi D
J Comb Chem; 2010 Jul; 12(4):430-4. PubMed ID: 20503973
[TBL] [Abstract][Full Text] [Related]
9. Antitumor potential of crown ethers: structure-activity relationships, cell cycle disturbances, and cell death studies of a series of ionophores.
Marjanović M; Kralj M; Supek F; Frkanec L; Piantanida I; Smuc T; Tusek-Bozić L
J Med Chem; 2007 Mar; 50(5):1007-18. PubMed ID: 17300184
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of 1,5-diazaanthraquinones as antitumour compounds.
Avendaño C; Pérez JM; Blanco Mdel M; de la Fuente JA; Manzanaro S; Vicent MJ; Martín MJ; Salvador-Tormo N; Menéndez JC
Bioorg Med Chem Lett; 2004 Aug; 14(15):3929-32. PubMed ID: 15225700
[TBL] [Abstract][Full Text] [Related]
11. Microwave-assisted synthesis of 4'-azaflavones and their N-alkyl derivatives with biological activities.
Yaşar A; Akpinar K; Burnaz NA; Küçük M; Karaoğlu SA; Doğan N; Yayli N
Chem Biodivers; 2008 May; 5(5):830-8. PubMed ID: 18493968
[TBL] [Abstract][Full Text] [Related]
12. Development of cobalt(3,4-diarylsalen) complexes as tumor therapeutics.
Gust R; Ott I; Posselt D; Sommer K
J Med Chem; 2004 Nov; 47(24):5837-46. PubMed ID: 15537341
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 2-amino-4-(7-azaindol-3-yl)pyrimidines as cyclin dependent kinase 1 (CDK1) inhibitors.
Huang S; Li R; Connolly PJ; Emanuel S; Middleton SA
Bioorg Med Chem Lett; 2006 Sep; 16(18):4818-21. PubMed ID: 16870444
[TBL] [Abstract][Full Text] [Related]
14. Relationship between structure and antiproliferative activity of 1-azaflavanones.
Kawaii S; Endo K; Tokiwano T; Yoshizawa Y
Anticancer Res; 2012 Jul; 32(7):2819-25. PubMed ID: 22753743
[TBL] [Abstract][Full Text] [Related]
15. In vitro cytotoxic activities of 2-alkyl-4,6-diheteroalkyl-1,3,5-triazines: new molecules in anticancer research.
Menicagli R; Samaritani S; Signore G; Vaglini F; Dalla Via L
J Med Chem; 2004 Sep; 47(19):4649-52. PubMed ID: 15341480
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis of 1-furfuryl-indolin-2-one derivatives and preliminary evaluation of their antitumor activities].
Dong XC; Zhou FS; Zheng JB; Wen R
Yao Xue Xue Bao; 2008 Jan; 43(1):54-9. PubMed ID: 18357732
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of N-substituted derivatives of 8,11-dimethyl-3,5-dioxo-4-azatricyclo[5.2.2.0(2,6)]undec-8-en-1-yl acetate and screening of cytotoxic activity of selected azatricycloundecane compounds.
Kossakowski J; Kuran B
Acta Pol Pharm; 2008; 65(3):371-5. PubMed ID: 18646557
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents.
Xue N; Yang X; Wu R; Chen J; He Q; Yang B; Lu X; Hu Y
Bioorg Med Chem; 2008 Mar; 16(5):2550-7. PubMed ID: 18226907
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities.
Son JK; Zhao LX; Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong TC; Jeong BS; Lee CS; Lee ES
Eur J Med Chem; 2008 Apr; 43(4):675-82. PubMed ID: 17673337
[TBL] [Abstract][Full Text] [Related]
20. Aza-retinoids as novel retinoid X receptor-specific agonists.
Farmer LJ; Marron KS; Canan Koch SS; Hwang CK; Kallel EA; Zhi L; Nadzan AM; Robertson DW; Bennani YL
Bioorg Med Chem Lett; 2006 May; 16(9):2352-6. PubMed ID: 16364638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]